Technical Support

InertSearch (Application Library)

Index

Application

Document No. Index

LB601 - 680 of Application List

No. Description Column
LB601 Analysis of Proteins MonoSelect C18 for HTS
LB602 Analysis of Methylhippuric acids InertSustain Cyano HP
LB603 Analysis of Steroids InertSustain Cyano HP
LB604 Analysis of Antidepressants InertSustain Cyano HP
LB605 Analysis of Antihistamines InertSustain Cyano HP
LB606 Analysis of Antihistamines InertSustain Cyano HP
LB607 Analysis of Plant hormones InertSustain Cyano
LB608 Analysis of Citral InertSustain Cyano
LB609 Analysis of Chlorophenols InertSustain Cyano
LB610 Analysis of Nortriptyline InertSustain Cyano
LB611 Analysis of Sertraline InertSustain Cyano
LB612 Analysis of Tetracaine InertSustain Cyano
LB613 Analysis of Isopropylmethylphenol InertSustain AQ-C18
LB614 Analysis of L-Ascorbic acid 2-glucoside Inertsil ODS-HL
LB615 Analysis of Cromolyn (Under the Condition of USP41-NF36, Cromolyn Sodium) InertSustain C18
LB616 Analysis of Levocetirizine (Under the Condition of USP41-NF36, Levocetirizine Dihydrochloride) Inertsil SIL-100A
LB617 Analysis of Levocetirizine Inertsil SIL-100A
LB618 Analysis of Pregabalin (Under the Condition of USP41-NF36, Pregabalin) Inertsil ODS-3
LB619 Analysis of Venlafaxine hydrochloride (Under the Condition of USP41-NF36, Venlafaxine Hydrochloride) InertSustain C8
LB620 Analysis of Venlafaxine hydrochloride (Under the Condition of USP41-NF36, Venlafaxine Tablets) InertSustain C18
LB621 Analysis of Venlafaxine hydrochloride (Under the Condition of USP41-NF36, Venlafaxine Hydrochloride Extended-Release Capsules) InertSustain C18
LB622 Analysis of Venlafaxine hydrochloride (Under the Condition of USP41-NF36, Venlafaxine Hydrochloride Extended-Release Capsules) InertSustain C18
LB623 Analysis of Etoposide phosphate (Under the Condition of draft for USP) InertSustain Phenyl
LB624 Analysis of Etoposide phosphate (Under the Condition of draft for USP) InertSustain Phenyl
LB625 Analysis of Prasugrel hydrochloride (Under the Condition of USP42-NF37) InertSustainSwift C18
LB626 Analysis of Prasugrel hydrochloride InertSustain C18
LB627 Analysis of Copovidone (Under the Condition of the draft for the Japanese Pharmacopoeia, (4) 1-Vinyl-2-pyrrolidone and vinyl acetate) Inertsil ODS-4
LB628 Analysis of Copovidone (Under the Condition of the draft for the Japanese Pharmacopoeia, (7) 2-Pyrrolidone) Inertsil ODS-3
LB629 Analysis of Telmisartan (Under the Condition of Japanese Pharmacopoeia, Telmisartan and Amlodipine Besilate Tablets) Inertsil C8-3
LB630 Analysis of Amlodipine besilate (Under the Condition of Japanese Pharmacopoeia, Telmisartan and Amlodipine Besilate Tablets) Inertsil C8-3
LB631 Analysis of Telmisartan and Amlodipine besilate (Under the Condition of Japanese Pharmacopoeia, Telmisartan and Amlodipine Besilate Tablets) Inertsil C8-3
LB632 Analysis of Telmisartan and Amlodipine besilate (Under the Condition of Japanese Pharmacopoeia, Telmisartan and Amlodipine Besilate Tablets) Inertsil C8-3
LB633 Analysis of Rivaroxaban (Under the Condition of draft for USP) InertSustainSwift C18
LB634 Analysis of Rivaroxaban (Under the Condition of draft for USP, Rivaroxaban Tablets) InertSustainSwift C18
LB635 Analysis of Levetiracetam (Under the Condition of draft for USP) InertSustain AQ-C18 HP
LB636 Analysis of Levetiracetam (Under the Condition of USP42-NF37 1S, Levetiracetam Tablets) InertSustainSwift C18
LB637 Analysis of Levetiracetam (Under the Condition of USP42-NF37 1S, Levetiracetam Extended-Release Tablets) InertSustain C8
LB638 Analysis of Levetiracetam (Under the Condition of USP42-NF37 1S, Levetiracetam Oral Solution) InertSustain C18
LB639 Analysis of Levetiracetam (Under the Condition of USP42-NF37 1S, Levetiracetam Oral Solution) InertSustainSwift C18
LB640 Analysis of Rosuvastatin Calcium (Under the Condition of draft for Japanese Pharmacopoeia, Rosuvastatin Calcium) InertSustain C18
LB641 Analysis of Rosuvastatin Calcium (Under the Condition of draft for Japanese Pharmacopoeia, Rosuvastatin Calcium) InertSustain C18
LB642 Analysis of Dipeptides InertSustain Amide
LB643 Analysis of Dipeptides InertSustain Amide
LB644 Analysis of Methylhippuric acids InertSustain Amide
LB645 Analysis of Glyphosate and Glufosinate InertSustain Amide
LB646 Analysis of Nucleotides and Nucleosides InertSustain Amide
LB647 Analysis of Nicotinamide Adenine Dinucleotide (NADH, NAD+) InertSustain Amide
LB648 Analysis of Nucleotide sugars InertSustain Amide
LB649 Analysis of ATP and its related compounds InertSustain Amide
LB650 Analysis of CTP and its related compounds InertSustain Amide
LB651 Analysis of GTP and its related compounds InertSustain Amide
LB652 Analysis of UTP and its related compounds InertSustain Amide
LB653 Analysis of Oligonucleotides InertSustain Amide
LB654 Analysis of Peptides InertSustain Amide
LB655 Analysis of Peptides InertSustain C18
LB656 Analysis of Peptides InertSustain AQ-C18
LB657 Analysis of Peptides InertSustain PFP
LB658 Analysis of Tamsulosin hydrochloride (Under the Condition of the Japanese harmacopoeia) Inertsil ODS-HL
LB659 Analysis of Tamsulosin hydrochloride (Under the Condition of the Japanese harmacopoeia) Inertsil ODS-HL
LB660 Analysis of Copovidone(Under the Condition of European Pharmacopoeia 10.0, Impurity A) Inertsil ODS-4
LB661 Analysis of BSA MonoSelect RP-mAb
LB662 Analysis of HSA MonoSelect RP-mAb
LB663 Analysis of IgG MonoSelect RP-mAb
LB664 Analysis of Insulin MonoSelect RP-mAb
LB665 Analysis of Lysozyme MonoSelect RP-mAb
LB666 Analysis of Myoglobin MonoSelect RP-mAb
LB667 Analysis of Ribonuclease A MonoSelect RP-mAb
LB668 Analysis of Nitrosoamines (NDMA, NDEA) InertSustain PFP
LB669 Analysis of Rosuvastatin calcium (Under the condition of the Japanese Pharmacopoeia (JP) ) InertSustainSwift C18
LB670 Analysis of Sucrose (Under the condition of the PDG (Pharmacopeial Discussion Group) Stage 2 Drafts) InertSphere Sugar-2
LB671 Analysis of Sucrose (Under the condition of the PDG (Pharmacopeial Discussion Group) Stage 2 Drafts) InertSphere Sugar-2
LB672 Analysis of Stearyl Glycyrrhetinate InertSustainSwift C8
LB673 Analysis of Limonene InertSustain C18
LB674 Analysis of β-Cryptoxanthin Inertsil ODS-3
LB675 Analysis of Carotenoids Inertsil ODS-P
LB676 Analysis of Anticancer drug and related substances InertSustain PFP HP
LB677 Analysis of Zebularine and Gemcitabine InertSustain C18 HP
LB678 Analysis of Validamycin InertSustain C18 HP
LB679 Analysis of Cetylpyridinium chloride InertSustain AX-C18
LB680 Analysis of bromate InertSustain C18